Intracellular fate of polymer therapeutics investigated by fluorescence lifetime imaging and fluorescence pattern analysis
Jazyk angličtina Země Česko Médium print
Typ dokumentu časopisecké články
PubMed
27762587
DOI
10.33549/physiolres.933423
PII: 933423
Knihovny.cz E-zdroje
- MeSH
- doxorubicin analogy a deriváty farmakokinetika MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- nanočástice MeSH
- nosiče léků * MeSH
- optické zobrazování metody MeSH
- polymery MeSH
- protinádorové látky farmakokinetika MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- Názvy látek
- doxorubicin MeSH
- nosiče léků * MeSH
- pirarubicin MeSH Prohlížeč
- polymery MeSH
- protinádorové látky MeSH
Nanocarriers bearing anticancer drugs are promising candidates to improve the efficacy of cancer therapy and minimize side effects. The most potent cytostatics used in the treatment of various cancers are anthracyclines, e.g. doxorubicin or pirarubicin. Recently, polymer therapeutics carrying anthracyclines have been intensively studied. The precise characterization of in vitro nanocarrier biological behavior brings a better understanding of the nanocarrier characteristics and enables prediction of the behavior of the nanocarrier during in vivo application. Advanced fluorescence detection methods, e.g. fluorescence lifetime imaging microscopy (FLIM), were successfully exploited to describe the properties of various polymeric nano-systems and contributed to a complex view of anthracyclines' intracellular transport and DNA intercalation. Here, we report the application of a specific technique for processing FLIM images, called fluorescence pattern decomposition, to evaluate early events after doxorubicin or pirarubicin treatment of cells. Moreover, we characterized changes in the intracellular localization and release of the anthracyclines during the incubation of cells with polymer nanotherapeutics based on poly[N-(2-hydroxypropyl)-methacrylamide] (pHPMA).
Citace poskytuje Crossref.org